Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vaxil Bio Ltd

+ Add to Watchlist

VAXL:IT

60.70 ILs 0.10 0.16%

As of 10:24:30 ET on 04/21/2015.

Snapshot for Vaxil Bio Ltd (VAXL)

Open: 63.10 Day's Range: 58.70 - 65.00 Volume: 133,323
Previous Close: 60.80 52wk Range: 30.00 - 215.01 1-Yr Rtn: -19.77%

Stock Chart for VAXL

No chart data available.
  • VAXL:IT 60.10
  • 1D
  • 1M
  • 1Y
60.80
Interactive VAXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VAXL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.3746
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 14.82
Shares Outstanding (M) 24.41
30 Day Average Volume 171,603
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VAXL

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for VAXL

Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.

Lior CarmonFounder/CEO/Head:ResearchJulian LevyPresident/CFO
Riva KovjazinDirector:ResearchOfira MoranClinical Trials Monitoring
More Company Profile & Key Executives for VAXL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil